Table 1.

Patient demographics.

Patient	Sex	Age	Method of diagnosis*	Forced vital capacity (L)	Total lung capacity (L)	DLCO (mL/min/mmHg)	Response to treatment	Outcome (after treatment)
1	M	66	Biopsy/HRCT	2.05	3.69	3.07	Responder	Dead (9 months)
2	F	51	HRCT	1.21	2.11	#	Responder	Alive
3	F	41	Biopsy/HRCT	1.63	3.3	3.93	Responder	Alive
4	F	71	HRCT	2.09	3.59	5.61	Responder	Dead (30 mths)
5	F	62	HRCT*	0.71	#	#	Responder	Transplanted (2 mths)
6	M	60	HRCT	2.52	4.18	4.3	Nonresponder	Dead (5 mths)
7	F	66	HRCT	1.07	2.89	2.94	Nonresponder	Dead (7 mths)
8	F	60	HRCT	1.75	3.02	1.39	Nonresponder	Dead (6 mths)
9	M	57	HRCT*	1.72	2.99	2.58	Nonresponder	Transplanted (4 mths)
10	F	50	HRCT*	1.43	2.59	#	Responder	Transplanted (4 mths)
11	F	46	HRCT*	1.25	2.39	3.9	Responder	Transplanted (11 mths)
12	M	61	HRCT*	1.88	3.86	3.3	Nonresponder	Transplanted (2 mths)
13	F	73	HRCT	1.60	3.17	3.2	Responder	Dead (9 mths)
14	M	47	Biopsy/HRCT	3.35	#	#	Responder	Alive

*All patients had a diagnostic HRCT. Three patients had diagnostic histology concurrently by VATS (video assisted thoracoscopy) and a further five patients had the histological confirmation confirmed in the explanted lung after transplantation.

^#Patients were unable to perform testing.